Sun Pharma’s RespiTrack mobile app to boost treatment compliance amongst asthma patients – ETCIO.com


ETCIO.com

Sun Pharma's RespiTrack mobile app to boost treatment compliance amongst asthma patients
ETCIO.com
Patient adherence to medical regimens is a major problem in chronic disease management. And adherence to asthma medication regimens tends to be very poor, with the reported rates of non-adherence to prescribed treatment regimen in India to be in the …
Sun Pharma launches mobile app for asthma patientsFinancial Express
Sun Pharma takes mobile app route to raise disease awareness: Abhay GandhiBusiness Standard

all 3 news articles »

View full post on asthma – Google News

Ajanta Pharma’s Generic Anti-Asthma Chewable Tablets Approved By US FDA – International Business Times


International Business Times

Ajanta Pharma's Generic Anti-Asthma Chewable Tablets Approved By US FDA
International Business Times
According to U.S. National Library of Medicine, Montelukast is used to prevent chest tightness, difficulty in breathing and wheezing and coughing caused by asthma. In addition, it is used to prevent the symptoms associated with seasonal allergies and
Ajanta Pharma launches generic asthma treatment tablets in USEconomic Times
Ajanta Pharma launches generic asthma treatment tabletsMoneycontrol.com
Ajanta Pharma launches anti-asthma tablets in USMyiris.com

all 17 news articles »

View full post on asthma – Google News